Campaigners Warn NHS Palantir System Could Enable Police and Immigration Access to Patient Data
Key Takeaways
- ▸Campaigners warn that Palantir's centralized NHS data platform could facilitate unauthorized access by UK police and immigration departments to confidential patient records
- ▸Palantir denies the allegations, stating that such usage would violate current law and contractual obligations with NHS England
- ▸The report is endorsed by major organizations including Amnesty International, Privacy International, and the Good Law Project, reflecting broad civil liberties concerns
Summary
Medical and legal rights campaigners have raised concerns that Palantir's Federated Data Platform (FDP)—a £330 million, seven-year contract to centralize England's health system data—could enable UK police and immigration departments to access confidential patient information. The report, authored by Medact and endorsed by organizations including the Good Law Project, Privacy International, and Amnesty International, warns that consolidating disparate health datasets onto a single Palantir platform could facilitate cross-government data sharing and potential state abuse of sensitive information.
Palantir has firmly denied the allegations, stating that using the FDP in this manner would be both illegal and in breach of contract with NHS England. The company emphasized that data processing is entirely under NHS control and that Palantir has no intention or means of enabling unauthorized access. However, the campaigners point to Palantir's history of deployment with controversial government agencies—including the US immigration agency ICE—as evidence of potential risks.
The report aims to inform NHS Trust Boards and other health governance bodies ahead of the FDP's rollout across England. Notably, the FDP is currently not mandatory, allowing local health organizations to raise concerns and opt out of implementation. Some health bodies, including Manchester ICB, have already delayed adoption of the system.
- NHS organizations retain the discretion to decline FDP implementation, and some have already delayed adoption pending resolution of data governance concerns
Editorial Opinion
The concerns raised by Medact and supporting organizations highlight a critical tension in healthcare data modernization: while centralized platforms like Palantir's can improve clinical efficiency and patient outcomes, they create unprecedented risks when combined with government surveillance capabilities. Palantir's contractual assurances may provide legal protection, but they offer little comfort given the company's documented work with immigration enforcement agencies and the historical pattern of scope creep in government data access. The fact that adoption remains voluntary suggests NHS organizations should exercise caution and demand robust, transparent safeguards before embracing a system that puts patient privacy in the hands of a company with deep ties to state surveillance infrastructure.
